Oligomerix, Inc
Publicly observedBronx, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Bronx | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Oligomerix, Inc | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | MHB5HVJVAK87 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant20 Aug 2025Publicly observed
NIH SBIR/STTR award: A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period
USD 1,499,525.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant20 Aug 2025Publicly observed
NIH SBIR/STTR award: A 13-Week Oral Gavage Toxicity Study of OLX-07010 in Beagle Dogs Followed by a 4-Week Recovery Period
USD 499,879.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.